查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2088926

上游生物製程市場：2026-2032年全球市場預測（按產品、技術、規模、細胞類型、應用和最終用戶分類）

Upstream Bioprocessing Market by Product, Technology, Scale, Cell Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，上游生物製程市場將成長至 667.3 億美元，複合年成長率為 15.21%。

主要市場統計數據
基準年 2025 247.6億美元
預計年份：2026年 284.2億美元
預測年份 2032 667.3億美元
複合年成長率 (%) 15.21%

上游生物製程執行摘要

上游生物製程是現代生物製藥生產的基礎，涵蓋細胞株開發、培養和補料最佳化、種子細胞擴增、生物反應器操作以及收穫前製程監測。單株抗體、重組蛋白、疫苗、生物相似藥以及新興的細胞和基因治療工作流程對高生產率、可重複性和監管可追溯性提出了更高的要求，從而推動了上游生物製程的發展。

上游生物製程領域的變革性變化

上游生物製程格局正因改進的補料分批培養和灌流培養策略、高密度細胞培養以及可縮短換型時間的模組化設施而重塑。一次性系統因其能減輕清洗驗證的負擔、支持多產品生產並提高操作柔軟性（尤其是在臨床和中小規模商業批次生產中）而持續受到青睞。

人工智慧對上游生物製程的累積影響

人工智慧（AI）應用於高品質、與情境相關的製程資料時，正成為上游生物製程一股切實的驅動力。人工智慧模型支援實驗設計、培養基最佳化、細胞培養監測、軟感測器開發、異常檢測以及對關鍵程式參數（例如pH值、溶解氧、溫度、活細胞密度、滲透壓、葡萄糖、乳酸和代謝物譜）的預測控制。

來自全球生物製造地的關鍵區域見解

亞太地區持續擴張，中國、印度、日本、韓國、新加坡和澳洲等國紛紛投資生物製藥產能、生物相似藥研發、疫苗平台和合約研發生產（CDMO）服務。儘管該地區擁有大規模的患者群體、成本優勢顯著的生產模式、較成熟的法規環境以及政府主導的生物製藥策略等優勢，但仍面臨諸多挑戰，例如如何進一步協調品質系統、確保原料穩定供應以及增強跨境供應鏈的韌性。

針對特定群體的關鍵洞察，協助策略市場定位

東協的重要性日益凸顯，這得益於新加坡成熟的生物製造生態系統，以及馬來西亞、泰國、越南、印尼和菲律賓不斷擴展的供應鏈服務、臨床開發支援和藥品生產管道。海灣合作理事會（GCC）成員國正將生物製造定位為更廣泛的醫療保健和經濟多元化戰略的一部分，沙烏地阿拉伯、阿拉伯聯合大公國和卡達都在投資生命科學基礎設施、本地生產能力和健康安全計畫。

來自上游生物製程關鍵國家的見解

美國在生物製藥創新、符合FDA監管的卓越生產系統、創業投資驅動的生物技術以及大規模CDMO生產能力方面處於主導地位。加拿大透過研究機構、對生物製藥生產的投資以及疫苗儲備計劃來支持上游生物製程，而墨西哥在整合區域供應鏈、藥品生產以及為北美醫療保健系統提供近市場生產方面的重要性日益提升。

為行業領導者提供的實用建議

產業領導者應優先考慮上游工程改進、穩健的細胞株開發和可擴展的培養基策略，以提高產量而不影響產品品質。投資於灌注平台、高通量篩檢、自動化取樣、閉迴路製程和整合製程分析技術，可降低開發風險並提高生產韌性。

調查方法

本執行摘要基於二手研究、監管資訊和產業證據，涵蓋上游生物製程技術、生技藥品生產趨勢、區域投資活動以及公共衛生領域的生產重點。本研究途徑參考的資訊資訊來源包括美國食品藥物管理局 (FDA)、歐洲藥品管理局 (EMA)、世界衛生組織 (WHO)、國際人用藥品註冊技術協調會 (ICH) 和各國監管機構的監管指南和公開信息，以及同行評審文獻、政府投資公告、公共採購資訊和檢驗的行業資料庫。

結論

上游生物製程正朝著更數據驅動、柔軟性和策略分散化的方向發展。生物製藥企業不再僅僅在產能上競爭，而是在製程知識、規模化生產速度、品質穩定性、污染控制以及管理全球市場複雜產品平臺的能力方面展開競爭。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 上游生物製程市場：依產品分類

  • 配件和耗材
  • 生物反應器
  • 培養基和試劑
    • 培養基
      • 基礎培養基
      • 化學成分明確的培養基
      • 無血清培養基
    • 試劑
      • 緩衝液和鹽
      • 細胞培養添加劑
      • 生長因子
  • 感測器和探頭
  • 免洗設備

第8章 上游生物製程市場：依技術分類

  • 氣升升式生物反應器
  • 固定台生物反應器
  • 免洗生物反應器
  • 攪拌槽式生物反應器
  • 波浪式生物反應器

第9章 上游生物製程市場：依規模分類

  • 實驗室規模
  • 大規模
  • 中試規模

第10章 上游生物製程市場：依細胞類型分類

  • 昆蟲細胞培養
  • 哺乳動物細胞培養
  • 微生物發酵
  • 植物細胞培養

第11章 上游生物製程市場：依應用領域分類

  • 細胞治療產品的生產
  • 基因治療載體的生產
  • 單株抗體生產
  • 重組蛋白生產
  • 疫苗生產

第12章 上游生物製程市場：依最終用戶分類

  • 學術研究機構
  • 生物製藥公司
  • 受託研究機構
  • 政府研究機構

第13章 上游生物製程市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章 上游生物製程市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 上游生物製程市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Avantor Inc
  • BBI-biotech GmbH
  • Bioengineering AG
  • Cellexus International Ltd
  • Corning Incorporated
  • Danaher Corporation
  • Distek Inc
  • Entegris Inc
  • Eppendorf SE
  • Esco Lifesciences Group Ltd
  • Fujimori Kogyo Co Ltd
  • Getinge AB
  • Kuhner AG
  • Lonza Group Ltd
  • Meissner Filtration Products Inc
  • Merck KGaA
  • OmniBRx Biotechnologies
  • Parker Hannifin Corporation
  • PBS Biotech Inc
  • PharmNXT Biotech
  • Saint-Gobain Performance Plastics
  • Sartorius AG
  • Shanghai Lepure Biotech Co Ltd
  • Solaris Biotech Srl
  • Thermo Fisher Scientific Inc
  • Tofflon Life Science Co Ltd
Product Code: MRR-A26E0E574508

The Upstream Bioprocessing Market is projected to grow by USD 66.73 billion at a CAGR of 15.21% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 24.76 billion
Estimated Year [2026] USD 28.42 billion
Forecast Year [2032] USD 66.73 billion
CAGR (%) 15.21%

Upstream Bioprocessing Executive Summary

Upstream bioprocessing is the foundation of modern biologics manufacturing, spanning cell line development, media and feed optimization, seed-train expansion, bioreactor operation, and process monitoring before harvest. Demand is being lifted by monoclonal antibodies, recombinant proteins, vaccines, biosimilars, and emerging cell and gene therapy workflows that require high productivity, reproducibility, and regulatory traceability.

The industry is moving from capacity-led expansion toward productivity-led operations. Manufacturers are prioritizing high-yield expression systems, chemically defined media, single-use bioreactors, closed processing, and process analytical technology to shorten development timelines while maintaining cGMP compliance. The strongest competitive advantage now comes from combining biological expertise with automation, data integrity, contamination control, and scalable manufacturing design.

Transformative Shifts in the Upstream Bioprocessing Landscape

The upstream bioprocessing landscape is being reshaped by intensified fed-batch and perfusion strategies, higher cell-density cultures, and modular facilities that reduce changeover time. Single-use systems continue to gain adoption because they can reduce cleaning validation burden, support multiproduct manufacturing, and improve operational flexibility, particularly for clinical and small-to-mid commercial batches.

At the same time, manufacturers face persistent constraints in skilled labor availability, raw material qualification, media security, extractables and leachables assessment, and technology transfer. Regulatory expectations from agencies such as the FDA and EMA continue to emphasize quality by design, process characterization, contamination control, and lifecycle validation, pushing organizations to build more robust upstream control strategies from early development through commercial manufacturing.

Cumulative Impact of Artificial Intelligence in Upstream Bioprocessing

Artificial intelligence is becoming a practical enabler in upstream bioprocessing when applied to high-quality, contextualized process data. AI models support design of experiments, media optimization, cell culture monitoring, soft-sensor development, anomaly detection, and predictive control of critical process parameters such as pH, dissolved oxygen, temperature, viable cell density, osmolality, glucose, lactate, and metabolite profiles.

The cumulative impact is faster process development, fewer failed runs, improved batch-to-batch consistency, and stronger process understanding. However, AI adoption must be governed through validated models, audit-ready data pipelines, human oversight, and GxP-compatible documentation. Industry leaders are treating AI not as a replacement for bioprocess science but as a decision-support layer that strengthens scale-up, technology transfer, root-cause analysis, and deviation management.

Key Regional Insights Across Global Biomanufacturing Hubs

Asia-Pacific is expanding as China, India, Japan, South Korea, Singapore, and Australia invest in biologics capacity, biosimilar development, vaccine platforms, and CDMO services. The region benefits from large patient populations, cost-competitive manufacturing, improving regulatory maturity, and government-backed biopharma strategies, while still requiring greater harmonization of quality systems, raw material security, and cross-border supply chain resilience.

North America remains a leading innovation and commercialization hub, supported by advanced biomanufacturing infrastructure, strong biotechnology financing, established FDA pathways, and dense networks of biopharma manufacturers, academic centers, and CDMOs. Europe retains strength through EMA-aligned regulatory depth, skilled technical labor, and mature clusters across Germany, France, the United Kingdom, Ireland, Switzerland, Italy, Spain, and the Nordics, with continued emphasis on quality systems, sustainability, and advanced therapy manufacturing.

Latin America is building biologics self-reliance through vaccine and biosimilar initiatives, with Brazil and Mexico acting as important anchors for regional pharmaceutical manufacturing and public health procurement. The Middle East is advancing healthcare diversification through sovereign investment and localized manufacturing strategies, especially in GCC markets. Africa is at an earlier stage but is gaining strategic importance through vaccine manufacturing partnerships, regional regulatory strengthening, and African Union ambitions to increase regional vaccine production by 2040.

Key Group Insights for Strategic Market Positioning

ASEAN is gaining relevance through Singapore's mature biomanufacturing ecosystem and growing participation from Malaysia, Thailand, Vietnam, Indonesia, and the Philippines in supply chain services, clinical development support, and pharmaceutical manufacturing. The GCC is positioning biomanufacturing as part of broader healthcare and economic diversification, with Saudi Arabia, the United Arab Emirates, and Qatar investing in life sciences infrastructure, local production capabilities, and health security programs.

The European Union provides a large harmonized regulatory environment, centralized EMA procedures, and strong public-private research networks, making it attractive for complex biologics, biosimilars, vaccines, and advanced therapy development. BRICS economies combine large domestic demand with expanding manufacturing capability, particularly through China, India, and Brazil, while Russia and South Africa remain important for regional access strategies and public health manufacturing objectives.

G7 countries continue to shape upstream bioprocessing through innovation funding, regulatory science, intellectual property frameworks, skilled workforces, and advanced manufacturing standards. NATO is not a healthcare market bloc, but its member countries are increasingly focused on supply chain resilience, critical inputs, biosecurity preparedness, and strategic manufacturing continuity, which indirectly influences biologics manufacturing and upstream bioprocessing strategy.

Key Country Insights in Upstream Bioprocessing

The United States leads in biologics innovation, FDA-regulated manufacturing excellence, venture-backed biotechnology, and large-scale CDMO capacity. Canada supports upstream bioprocessing through research institutions, biologics manufacturing investments, and vaccine preparedness programs, while Mexico is becoming more relevant for regional supply chain integration, pharmaceutical manufacturing, and near-market production for North American healthcare systems.

Brazil is Latin America's leading biologics and vaccine market, supported by public health procurement and domestic production partnerships. In Europe, the United Kingdom maintains strengths in cell and gene therapy, bioprocess research, and clinical translation; Germany leads in engineering, automation, and biologics manufacturing; France combines vaccine heritage with biomanufacturing investment; Italy and Spain offer strong pharmaceutical manufacturing bases and clinical research networks; and Russia retains domestic biologics capabilities shaped by local market access needs and national procurement priorities.

China is scaling biologics and biosimilars through capacity additions, policy support, and a large clinical pipeline. India is a global biosimilar and vaccine manufacturing powerhouse with cost-efficient development capabilities and deep process know-how. Japan emphasizes quality, automation, and high-value biologics, while South Korea has become a major CDMO and biosimilar manufacturing hub supported by advanced facilities and export-oriented production. Australia contributes through clinical trials, biomedical research, translational science, and regional manufacturing partnerships.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize upstream process intensification, robust cell line development, and scalable media strategies that improve yield without compromising product quality. Investments in perfusion-ready platforms, high-throughput screening, automated sampling, closed processing, and integrated process analytical technology can reduce development risk and improve manufacturing resilience.

Executives should also strengthen supplier qualification, dual-source critical raw materials, assess single-use component risk, and maintain build-for-transfer documentation to support global launches. AI should be deployed through validated use cases, beginning with predictive monitoring, media optimization, soft sensors, and deviation prevention. Organizations that align scientific depth, digital governance, regulatory readiness, and resilient sourcing will be best positioned to advance biologics, biosimilars, vaccines, and next-generation therapies.

Research Methodology

This executive summary is built from secondary research, regulatory intelligence, and industry evidence covering upstream bioprocessing technologies, biologics manufacturing trends, regional investment activity, and public health manufacturing priorities. Sources reviewed in this research approach include regulatory guidance and public information from the FDA, EMA, WHO, ICH, and national agencies, along with peer-reviewed literature, government investment announcements, public procurement information, and validated industry databases.

The methodology emphasizes triangulation across technology adoption, end-user demand indicators, manufacturing capability, regulatory environment, and regional policy direction. Insights are evaluated for consistency across multiple public sources and interpreted through a bioprocessing value-chain lens that includes cell culture systems, media and reagents, bioreactors, automation, analytics, CDMOs, academic translational networks, and biopharmaceutical manufacturers.

Conclusion

Upstream bioprocessing is entering a more data-driven, flexible, and strategically distributed phase. Biologics manufacturers are no longer competing only on capacity; they are competing on process knowledge, speed to scale, quality consistency, contamination prevention, and the ability to manage complex product pipelines across global markets.

The next stage of leadership will depend on integrating biological optimization with automation, AI-enabled control, resilient sourcing, and region-specific manufacturing strategies. Organizations that treat upstream development as a strategic asset will be better prepared to accelerate approvals, control costs, maintain compliance, and meet rising global demand for advanced biologic therapies.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Upstream Bioprocessing Market, by Product

  • 7.1. Accessories And Consumables
  • 7.2. Bioreactors
  • 7.3. Media And Reagents
    • 7.3.1. Media
      • 7.3.1.1. Basal Media
      • 7.3.1.2. Chemically Defined Media
      • 7.3.1.3. Serum-Free Media
    • 7.3.2. Reagents
      • 7.3.2.1. Buffers And Salts
      • 7.3.2.2. Cell Culture Supplements
      • 7.3.2.3. Growth Factors
  • 7.4. Sensors And Probes
  • 7.5. Single-Use Equipment

8. Upstream Bioprocessing Market, by Technology

  • 8.1. Airlift Bioreactors
  • 8.2. Fixed-Bed Bioreactors
  • 8.3. Single-Use Bioreactors
  • 8.4. Stirred-Tank Bioreactors
  • 8.5. Wave Bioreactors

9. Upstream Bioprocessing Market, by Scale

  • 9.1. Lab Scale
  • 9.2. Large Scale
  • 9.3. Pilot Scale

10. Upstream Bioprocessing Market, by Cell Type

  • 10.1. Insect Cell Culture
  • 10.2. Mammalian Cell Culture
  • 10.3. Microbial Fermentation
  • 10.4. Plant Cell Culture

11. Upstream Bioprocessing Market, by Application

  • 11.1. Cell Therapy Production
  • 11.2. Gene Therapy Vector Production
  • 11.3. Monoclonal Antibody Production
  • 11.4. Recombinant Protein Production
  • 11.5. Vaccine Production

12. Upstream Bioprocessing Market, by End User

  • 12.1. Academic And Research Institutes
  • 12.2. Biopharmaceutical Companies
  • 12.3. Contract Research Organizations
  • 12.4. Government Laboratories

13. Upstream Bioprocessing Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Upstream Bioprocessing Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Upstream Bioprocessing Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Avantor Inc
  • 17.2. BBI-biotech GmbH
  • 17.3. Bioengineering AG
  • 17.4. Cellexus International Ltd
  • 17.5. Corning Incorporated
  • 17.6. Danaher Corporation
  • 17.7. Distek Inc
  • 17.8. Entegris Inc
  • 17.9. Eppendorf SE
  • 17.10. Esco Lifesciences Group Ltd
  • 17.11. Fujimori Kogyo Co Ltd
  • 17.12. Getinge AB
  • 17.13. Kuhner AG
  • 17.14. Lonza Group Ltd
  • 17.15. Meissner Filtration Products Inc
  • 17.16. Merck KGaA
  • 17.17. OmniBRx Biotechnologies
  • 17.18. Parker Hannifin Corporation
  • 17.19. PBS Biotech Inc
  • 17.20. PharmNXT Biotech
  • 17.21. Saint-Gobain Performance Plastics
  • 17.22. Sartorius AG
  • 17.23. Shanghai Lepure Biotech Co Ltd
  • 17.24. Solaris Biotech Srl
  • 17.25. Thermo Fisher Scientific Inc
  • 17.26. Tofflon Life Science Co Ltd

LIST OF FIGURES

  • FIGURE 1. GLOBAL UPSTREAM BIOPROCESSING MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL UPSTREAM BIOPROCESSING MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL UPSTREAM BIOPROCESSING MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL UPSTREAM BIOPROCESSING MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL UPSTREAM BIOPROCESSING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL UPSTREAM BIOPROCESSING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ACCESSORIES AND CONSUMABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ACCESSORIES AND CONSUMABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ACCESSORIES AND CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BIOREACTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOREACTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BIOREACTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDIA AND REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDIA AND REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDIA AND REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BASAL MEDIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BASAL MEDIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BASAL MEDIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CHEMICALLY DEFINED MEDIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CHEMICALLY DEFINED MEDIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CHEMICALLY DEFINED MEDIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BUFFERS AND SALTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BUFFERS AND SALTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BUFFERS AND SALTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CELL CULTURE SUPPLEMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CELL CULTURE SUPPLEMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CELL CULTURE SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL GROWTH FACTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL GROWTH FACTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SENSORS AND PROBES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SENSORS AND PROBES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SENSORS AND PROBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SINGLE-USE EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SINGLE-USE EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SINGLE-USE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL AIRLIFT BIOREACTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL AIRLIFT BIOREACTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL AIRLIFT BIOREACTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL FIXED-BED BIOREACTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL FIXED-BED BIOREACTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL FIXED-BED BIOREACTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SINGLE-USE BIOREACTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SINGLE-USE BIOREACTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SINGLE-USE BIOREACTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL STIRRED-TANK BIOREACTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL STIRRED-TANK BIOREACTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL STIRRED-TANK BIOREACTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL WAVE BIOREACTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL WAVE BIOREACTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL WAVE BIOREACTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL LAB SCALE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL LAB SCALE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL LAB SCALE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL LARGE SCALE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL LARGE SCALE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL LARGE SCALE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PILOT SCALE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PILOT SCALE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PILOT SCALE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL INSECT CELL CULTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL INSECT CELL CULTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL INSECT CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MAMMALIAN CELL CULTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MAMMALIAN CELL CULTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MAMMALIAN CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MICROBIAL FERMENTATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MICROBIAL FERMENTATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MICROBIAL FERMENTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PLANT CELL CULTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PLANT CELL CULTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PLANT CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CELL THERAPY PRODUCTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CELL THERAPY PRODUCTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CELL THERAPY PRODUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL GENE THERAPY VECTOR PRODUCTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL GENE THERAPY VECTOR PRODUCTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL GENE THERAPY VECTOR PRODUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MONOCLONAL ANTIBODY PRODUCTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MONOCLONAL ANTIBODY PRODUCTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MONOCLONAL ANTIBODY PRODUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL RECOMBINANT PROTEIN PRODUCTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL RECOMBINANT PROTEIN PRODUCTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL RECOMBINANT PROTEIN PRODUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL VACCINE PRODUCTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL VACCINE PRODUCTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL VACCINE PRODUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ACADEMIC AND RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ACADEMIC AND RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ACADEMIC AND RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL BIOPHARMACEUTICAL COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL BIOPHARMACEUTICAL COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIOPHARMACEUTICAL COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL GOVERNMENT LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL GOVERNMENT LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL GOVERNMENT LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. GCC UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 183. GCC UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 184. GCC UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 185. GCC UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2032 (USD MILLION)
  • TABLE 186. GCC UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 187. GCC UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 188. GCC UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2032 (USD MILLION)
  • TABLE 189. GCC UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. GCC UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. GCC UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. G7 UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 213. G7 UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 214. G7 UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 215. G7 UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2032 (USD MILLION)
  • TABLE 216. G7 UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 217. G7 UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 218. G7 UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2032 (USD MILLION)
  • TABLE 219. G7 UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. G7 UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 221. G7 UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. NATO UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 223. NATO UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 224. NATO UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 225. NATO UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2032 (USD MILLION)
  • TABLE 226. NATO UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 227. NATO UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 228. NATO UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2032 (USD MILLION)
  • TABLE 229. NATO UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. NATO UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. NATO UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. CANADA UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 244. CANADA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 245. CANADA UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 246. CANADA UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2032 (USD MILLION)
  • TABLE 247. CANADA UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 248. CANADA UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 249. CANADA UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2032 (USD MILLION)
  • TABLE 250. CANADA UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. CANADA UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 252. CANADA UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 253. MEXICO UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 254. MEXICO UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 255. MEXICO UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 256. MEXICO UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2032 (USD MILLION)
  • TABLE 257. MEXICO UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 258. MEXICO UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 259. MEXICO UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2032 (USD MILLION)
  • TABLE 260. MEXICO UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. MEXICO UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 262. MEXICO UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 263. BRAZIL UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 264. BRAZIL UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 265. BRAZIL UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 266. BRAZIL UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2032 (USD MILLION)
  • TABLE 267. BRAZIL UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 268. BRAZIL UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 269. BRAZIL UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2032 (USD MILLION)
  • TABLE 270. BRAZIL UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. BRAZIL UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 272. BRAZIL UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED KINGDOM UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED KINGDOM UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED KINGDOM UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED KINGDOM UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED KINGDOM UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED KINGDOM UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED KINGDOM UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED KINGDOM UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED KINGDOM UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED KINGDOM UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 283. GERMANY UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 284. GERMANY UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 285. GERMANY UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 286. GERMANY UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2032 (USD MILLION)
  • TABLE 287. GERMANY UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 288. GERMANY UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 289. GERMANY UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2032 (USD MILLION)
  • TABLE 290. GERMANY UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. GERMANY UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 292. GERMANY UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 293. FRANCE UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 294. FRANCE UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 295. FRANCE UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 296. FRANCE UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2032 (USD MILLION)
  • TABLE 297. FRANCE UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 298. FRANCE UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 299. FRANCE UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2032 (USD MILLION)
  • TABLE 300. FRANCE UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 301. FRANCE UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 302. FRANCE UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 303. RUSSIA UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 304. RUSSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 305. RUSSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 306. RUSSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2032 (USD MILLION)
  • TABLE 307. RUSSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 308. RUSSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 309. RUSSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2032 (USD MILLION)
  • TABLE 310. RUSSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 311. RUSSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 312. RUSSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 313. ITALY UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 314. ITALY UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 315. ITALY UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 316. ITALY UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2032 (USD MILLION)
  • TABLE 317. ITALY UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 318. ITALY UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 319. ITALY UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2032 (USD MILLION)
  • TABLE 320. ITALY UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 321. ITALY UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 322. ITALY UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 323. SPAIN UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 324. SPAIN UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 325. SPAIN UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 326. SPAIN UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2032 (USD MILLION)
  • TABLE 327. SPAIN UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 328. SPAIN UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 329. SPAIN UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2032 (USD MILLION)
  • TABLE 330. SPAIN UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 331. SPAIN UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 332. SPAIN UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 333. CHINA UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 334. CHINA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 335. CHINA UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 336. CHINA UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2032 (USD MILLION)
  • TABLE 337. CHINA UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 338. CHINA UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 339. CHINA UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2032 (USD MILLION)
  • TABLE 340. CHINA UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 341. CHINA UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 342. CHINA UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 343. INDIA UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 344. INDIA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 345. INDIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 346. INDIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2032 (USD MILLION)
  • TABLE 347. INDIA UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 348. INDIA UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 349. INDIA UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2032 (USD MILLION)
  • TABLE 350. INDIA UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 351. INDIA UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 352. INDIA UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 353. JAPAN UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 354. JAPAN UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 355. JAPAN UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 356. JAPAN UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA, 2018-2032 (USD MILLION)
  • TABLE 357. JAPAN UPSTREAM BIOPROCESSING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 358. JAPAN UPSTREAM BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 359. JAPAN UPSTREAM BIOPROCESSING MARKET SIZE, BY SCALE, 2018-2032 (USD MILLION)
  • TABLE 360. JAPAN UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 361. JAPAN UPSTREAM BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 362. JAPAN UPSTREAM BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 363. AUSTRALIA UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 364. AUSTRALIA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 201